Reaction Details |
| Report a problem with these data |
Target | 5-hydroxytryptamine receptor 1F |
---|
Ligand | BDBM50207400 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1631224 (CHEMBL3873930) |
---|
Ki | >2970000±n/a nM |
---|
Citation | Blanco, MJ; Benesh, DR; Knobelsdorf, JA; Khilevich, A; Cortez, GS; Mokube, F; Aicher, TD; Groendyke, TM; Marmsater, FP; Tang, TP; Johnson, KW; Clemens-Smith, A; Muhlhauser, MA; Swanson, S; Catlow, J; Emkey, R; Johnson, MP; Schkeryantz, JM Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache. Bioorg Med Chem Lett27:323-328 (2017) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
5-hydroxytryptamine receptor 1F |
---|
Name: | 5-hydroxytryptamine receptor 1F |
Synonyms: | 5-HT-1F | 5-HT1F | 5-hydroxytryptamine receptor 1F | 5HT1F_HUMAN | HTR1EL | HTR1F | Serotonin (5-HT) receptor | Serotonin 1f (5-HT1f) receptor | Serotonin receptor 1F |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 41724.68 |
Organism: | Homo sapiens (Human) |
Description: | 5-HT1F HTR1F HUMAN::P30939 |
Residue: | 366 |
Sequence: | MDFLNSSDQNLTSEELLNRMPSKILVSLTLSGLALMTTTINSLVIAAIIVTRKLHHPANY
LICSLAVTDFLVAVLVMPFSIVYIVRESWIMGQVVCDIWLSVDITCCTCSILHLSAIALD
RYRAITDAVEYARKRTPKHAGIMITIVWIISVFISMPPLFWRHQGTSRDDECIIKHDHIV
STIYSTFGAFYIPLALILILYYKIYRAAKTLYHKRQASRIAKEEVNGQVLLESGEKSTKS
VSTSYVLEKSLSDPSTDFDKIHSTVRSLRSEFKHEKSWRRQKISGTRERKAATTLGLILG
AFVICWLPFFVKELVVNVCDKCKISEEMSNFLAWLGYLNSLINPLIYTIFNEDFKKAFQK
LVRCRC
|
|
|
BDBM50207400 |
---|
n/a |
---|
Name | BDBM50207400 |
Synonyms: | CHEMBL3899832 |
Type | Small organic molecule |
Emp. Form. | C22H19N5O4 |
Mol. Mass. | 417.4174 |
SMILES | CC(=O)c1ccc(OCc2ccc(Oc3cc(ccn3)-c3nn[nH]n3)cc2)c(C)c1O |
Structure |
|